Epiminder Limited (ASX:EPI)

Market Cap	138.47M
Revenue (ttm)	648.18K -87.5%
Net Income	-38.14M
EPS	-0.44
Shares Out	216.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,507
Average Volume	88,329
Open	0.6400
Previous Close	0.6300
Day's Range	0.6300 - 0.6500
52-Week Range	0.5950 - 1.4900
Beta	n/a
RSI	37.55
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPI

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.